类风湿关节炎相关间质性肺病或支气管扩张患者的总死亡率和病因特异性死亡率风险
基于Mass General Brigham Biobank的回顾性队列研究,比较221例类风湿关节炎相关肺病(RA-LD,含151例RA-ILD和70例RA-BR)与980例无肺病RA对照。RA-LD总死亡率更高(34.0 vs 13.1/1000人年;HR 1.97,95%CI 1.43-2.70),呼吸道和感染相关死亡增加,RA-BR癌症死亡更高。
要点
- RA-LD患者总死亡率显著高于无肺病RA患者(HR 1.97,95%CI 1.43-2.70)。
- RA-LD呼吸道死亡率升高(sdHR 6.68,95%CI 3.19-14.00),尤以RA-ILD为著。
- RA-BR癌症死亡率升高(sdHR 2.89,95%CI 1.11-7.47)。
核心结论
- RA-LD尤其RA-ILD与更高的死亡率相关,特别是呼吸道和感染相关死亡。
- RA-BR与呼吸道和癌症死亡率升高相关。
- 作者认为需要更大规模的研究,这些发现强调需要改进RA-LD的治疗、有效的感染预防和警惕的癌症监测。
研究设计与样本
- 回顾性队列研究,使用Mass General Brigham Biobank(波士顿,马萨诸塞州)。
- 比较RA-LD病例与按日历日期、年龄、性别和RA病程匹配的RA无肺病对照。
- RA-LD通过病历回顾和胸部影像验证,包括临床明显的RA相关间质性肺病(RA-ILD)和/或RA相关支气管扩张(RA-BR)。
主要发现
- 分析221例RA-LD(151例RA-ILD和70例RA-BR)和980例RA无肺病对照。
- RA-LD患者总死亡率更高(34.0 vs 13.1/1000人年;HR 1.97,95%CI 1.43-2.70)。
- RA-LD患者感染相关死亡更常见(7% vs 3%,P=0.002)。
- RA-LD与呼吸道死亡(13.1 vs 1.7/1000人年;sdHR 6.68,95%CI 3.19-14.00)和肺部感染相关死亡(6.3 vs 1.4/1000人年;sdHR 3.33,95%CI 1.32-8.37)增加相关,尤其在RA-ILD患者中。
- RA-BR患者癌症死亡率更高(8.6 vs 2.3/1000人年;sdHR 2.89,95%CI 1.11-7.47)。
关键数值与推荐
- 总死亡率使用Cox回归分析,病因特异性死亡率使用Fine和Gray模型估计亚分布风险比(sdHR)和95%置信区间(CI),并针对倾向评分进行调整。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate total and cause-specific mortality risk among rheumatoid arthritis-associated lung disease (RA-LD) compared with RA patients without lung disease (RA-no LD). METHODS: We conducted a retrospective cohort study using the Mass General Brigham Biobank (Boston, MA), comparing RA-LD cases to RA-no LD comparators matched by calendar date, age, sex and RA duration. RA-LD was verified by medical record review and chest imaging for clinically apparent RA-associated interstitial lung disease (RA-ILD) and/or RA-associated bronchiectasis (RA-BR). Outcomes included total and cause-specific mortality (respiratory, cancer, cardiovascular, infection). Total mortality was analysed using Cox regression, and cause-specific mortality was analyzed using Fine and Gray models estimating subdistribution hazard ratios (sdHR) and 95% confidence intervals (CI), adjusted for propensity scores. RESULTS: We analyzed 221 RA-LD cases (151 RA-ILD and 70 RA-BR) and 980 RA-no LD comparators. RA-LD patients had higher total mortality (34.0 vs 13.1 per 1000 person-years; HR 1.97, 95%CI 1.43-2.70). Infection-related mortality was more common in RA-LD patients (7% vs 3%, P = 0.002). RA-LD was associated with increased respiratory (13.1 vs 1.7 per 1000 person-years; sdHR 6.68, 95%CI 3.19-14.00) and lung infection-related mortality (6.3 vs 1.4 per 1000 person-years; sdHR 3.33, 95%CI 1.32-8.37), particularly in RA-ILD patients. RA-BR patients had higher cancer mortality (8.6 vs 2.3 per 1000 person-years; sdHR 2.89, 95%CI 1.11-7.47). CONCLUSION: RA-LD, particularly RA-ILD, is associated with higher mortality, especially respiratory and infection-related mortality. RA-BR is associated with increased respiratory and cancer mortality. While larger studies are needed, these findings emphasize the need for improved treatments for RA-LD, effective infection prevention, and vigilant cancer surveillance.
引用
- Zhang Q, Qi Y, Wang X, et al. Risk of total and cause-specific mortality in patients with rheumatoid arthritis-associated interstitial lung disease or bronchiectasis. Rheumatology (Oxford). 2025. PMID: 40644608. doi:10.1093/rheumatology/keaf380
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。